Education
About Us
Working with TipRanks
Follow Us
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
ASX:IMR
IMR Stock Chart & Stats
AU$1.64
--
Market closed
AU$1.64
--
Day’s Range― - ―
52-Week RangeAU$1.12 - AU$2.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)287.54K
Market Cap
AU$704.98M
Enterprise ValueAU$358.01M
Total Cash (Recent Filing)AU$50.34M
Total Debt (Recent Filing)AU$24.81M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Feb 25, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding320,947,020
10 Day Avg. Volume240,875
30 Day Avg. Volume287,535
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)-25.56
Price to Sales (P/S)196.53
P/FCF Ratio-12.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.71Price Target Upside65.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendConsistent revenue expansion over multiple years signals commercial traction for Imricor’s MRI-guided electrophysiology products. A growing top line provides a foundation to scale clinical adoption, support recurring consumable sales, and absorb fixed costs if margins improve over time.
Recurring Consumables Revenue ModelA consumables-led revenue stream tied to procedures creates durable, recurring revenue potential once hospital adoption occurs. This model encourages repeat purchases, increases customer lifetime value, and lends predictable annuity-like income as procedures scale across installed sites.
Niche MRI-guided Product DifferentiationImricor’s focus on MR-conditional EP catheters targets a specialized, higher-barrier segment of image-guided cardiac ablation. Technology differentiation and regulatory/device compatibility requirements can create defensible market positioning and higher switching costs for customers over the long term.
Bears Say
Severe Negative MarginsDeep and persistent negative gross and net margins indicate structural unit-economics problems: revenue does not cover direct costs. This undermines free cash generation, requires corrective pricing or cost redesign, and makes sustainable scaling unlikely without fundamental operational changes.
Negative Shareholders' EquityNegative equity reflects liabilities exceeding assets and signals solvency stress. It constrains access to non-dilutive funding, weakens creditor confidence, and increases the probability of dilutive capital raises or restricted financing terms, limiting strategic flexibility over months ahead.
Sustained Cash Burn And Negative Free Cash FlowLarge and ongoing operating cash deficits force reliance on financing inflows to fund operations. Persistent cash burn shortens runway for commercialization and R&D, pressures management to seek dilutive capital or curtail investments, and raises execution risk during scaling.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh News
IMR FAQ
What was Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price range in the past 12 months?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh lowest share price was AU$1.11 and its highest was AU$2.25 in the past 12 months.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap is AU$704.98M.
When is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date is Feb 25, 2026 which is in 4 days.
How were Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s earnings last quarter?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh released its earnings results on Aug 25, 2025. The company reported -AU$0.041 earnings per share for the quarter, missing the consensus estimate of -AU$0.02 by -AU$0.021.
Is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh overvalued?
According to Wall Street analysts Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price is currently Undervalued.
Does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh pay dividends?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh does not currently pay dividends.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate is -0.03.
How many shares outstanding does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh have?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 320,947,020 shares outstanding.
What happened to Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price movement after its last earnings report?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh reported an EPS of -AU$0.041 in its last earnings report, missing expectations of -AU$0.02. Following the earnings report the stock price went down -0.372%.
Which hedge fund is a major shareholder of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh?
Currently, no hedge funds are holding shares in AU:IMR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$2.71 (65.24% Upside)
AU$2.71 (65.24% Upside)
Blogger Sentiment
Bullish
AU:IMR Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
102.70%
12-Months-Change
Fundamentals
Return on Equity
-432.03%
Trailing 12-Months
Asset Growth
634.84%
Trailing 12-Months
Company Description
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR) Earnings & Revenues
IMR Stock 12 Month Forecast
Average Price Target
AU$2.71
▲(65.24% Upside)
Technical Analysis
Impedimed Limited
―
HeraMED Ltd.
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Options Prices
Currently, No data available
---